NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/10/2022
Voltar para busca
Dado oficial do USPTO
V
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
08/10/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42
Data de depósito
03/08/2020
Data de registro
05/10/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/10/2021
Última transação
05/10/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
CIANCI, RYAN MICHAEL
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a "V" comprised of numerous dark shaded circles. A series of light shaded circles appear to the left of the "V".
Titulares e representantes
Titulares
VECTURA LIMITED
Representantes
Molly B. Markley Young, Basile, Hanlon & MacFarlane P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical additives for use in the manufacture of medical preparations
Classe 5
Medical preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparations for medical purposes for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; biological preparations for medical purposes for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparations for treating pulmonary diseases via inhalation; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems
Classe 10
Medical apparatus and instrumentsnamely inhalers; drug delivery devicesnamely inhalers; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; component parts and fittings for all the aforesaid goods
Classe 42
Scientific research relating to medical preparations and drug delivery devices; development and design medical preparations and drug delivery devices; analysisinvestigation in the form of testing of medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/03/2022
FIMP
FINAL DISPOSITION PROCESSED
21/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/07/2021
PUBO
PUBLISHED FOR OPPOSITION
20/07/2021
GPNX
NOTIFICATION PROCESSED BY IB
19/07/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/06/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/06/2021
ALIE
ASSIGNED TO LIE
15/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/06/2021
RFNT
REFUSAL PROCESSED BY IB
04/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/12/2020
RFRR
REFUSAL PROCESSED BY MPU
16/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/12/2020
DOCK
ASSIGNED TO EXAMINER
24/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace V ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.